Larry H. Danziger
 |
Larry H. Danziger, PharmD Professor Pharmacy Practice | |
| danziger@uic.edu | ||
| Phone | 312-996-0892 | |
| Fax | 312-413-0238 | |
| Office | 310 AOB, MC672 | |
| US Mail | 833 South Wood Street, RM164 MC886, Chicago, IL 60612 | |
| Research Interests Dr. Danziger's research interests include surgical infectious disease, the unusual properties of antimicrobial agents and pharmacological aspects of the patients with infectious diseases. Education |
| 1978 | Doctor of Pharmacy degree, University of Cincinnati |
|---|---|
| 1976 | Bachelor of Science in Pharmacy, University of Illinois (Chicago) |
| 1973 | Bachelor of Arts in History, University of Illinois (Urbana) |
Current UIC Appointments
| 2008 to Present | Interim Vice Chancellor for Research |
|---|---|
| 1995 to Present | Professor of Pharmacy Practice, Department of Pharmacy Practice; Co-Director, Section of Infectious Diseases Pharmacotherapy, Department of Pharmacy Practice; Assistant Professor of Pharmacy in Medicine, Division, Infectious Diseases, College of Medicine |
| 1999 to 2007 | Associate Vice Chancellor for Research |
Representative Publications
- Jain R, Schriever CA, Danziger LH, Cho SH, Rubinstein I. The IS6110 repetitive DNA element of Mycobacterium tuberculosis is not detected in exhaled breath condensate of patients with active pulmonary tuberculosis. Respiration. 2007;74(3):329-33.
- Slover CM, Rodvold KA, Danziger LH. Tigecycline: a novel broad-spectrum antimicrobial. Ann Pharmacother.2007 Jun;41(6):965-72.
- Joseph JM, Jain R, Danziger LH. Micafungin: a new echinocandin antifungal. Pharmacotherapy. 2007 Jan;27(1):53-67. Review.
- It okazu GS, Schwartz DN, Garey KW, Rodvold KA,, Danziger LH, Weinstein RA. Pharmacists' perceptions of the effectiveness of antimicrobial control programs. Am J Health Syst Pharm. 2006 Dec 15;63(24):2504-8.
- Sprandel KA, Drusano GL, Hecht DW, Rotschafer JC, Danziger LH, Rodvold KA. Population pharmacokinetic modeling and Monte Carlo simulation of
varying doses of intravenous metronidazole. Diagn Microbiol Infect Dis. 2006 Aug;55(4):303-9. - Johnson MD, Kleinberg M, Danziger L, Ostrosky-Zeichner L. Pharmacoeconomics of antifungal pharmacotherapy--challenges and future directions.Expert Opin Pharmacother. 2005 Dec;6(15):2617-32. Review.
- Suda KJ, Garey K, Danziger LH. Treatment failures secondary to drug interactions with divalent cations and fluoroquinolone.Pharm World Sci. 2005 Apr;27(2):81-2.
